Clinical Trial Update: A Study of [14 C]-Pevonedistat in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of 14C-labeled pevonedistat in participants with advanced solid tumors has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• pevonedistat (14C-labeled) (pevonedistat)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Advanced Solid Tumors, Neoplasms, Advanced Solid | Phase 1 | Status: COMPLETED | Results posted: 2019-05-08